Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics Revenue

Amicus Therapeutics had revenue of $126.67M in the quarter ending June 30, 2024, with 34.04% growth. This brings the company's revenue in the last twelve months to $455.66M, up 29.98% year-over-year. In the year 2023, Amicus Therapeutics had annual revenue of $399.36M with 21.30% growth.

• Revenue (ttm): $455.66M
• Revenue Growth: +29.98%
• P/S Ratio: 7.59
• Revenue / Employee: $881,344
• Employees: 517
• Market Cap: 3.41B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	399.36M	70.12M	21.30%
Dec 31, 2022	329.23M	23.72M	7.76%
Dec 31, 2021	305.51M	44.63M	17.11%
Dec 31, 2020	260.89M	78.65M	43.16%
Dec 31, 2019	182.24M	90.99M	99.72%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.